Morinda citrifolia

Lim, T. K.

doi:10.1007/978-94-007-5653-3_35

Cited by 3 publications

(2 citation statements)

References 139 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The plant was 306 | Pharmaceutical Sciences, December 2017, 23, 301-307 Shami known to produce alkaloids as secondary metabolites and these had antibacterial properties. 8,19,20 Costa, Pinheiro 21 reported that alkaloids O-methylmoschatoline, lysicamine and liriodenine from the bark of Guatteria hispida (Annoaceae) had antibacterial activity against S. epidermidis. Yang,Zuo 22 reported that the new indole alkaloids from the twigs of Kopsia hainanensis (Apocyanaceae) exhibited antibacterial properties against S. aureus.…”

Section: Discussionmentioning

confidence: 99%

The Effect of Alkaloidal Fraction from Annona squamosa L. against Pathogenic Bacteria with Antioxidant Activities

Shami¹

2017

Pharm Sci

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

The Effect of Alkaloidal Fraction from Annona squamosa L. against Pathogenic Bacteria with Antioxidant Activities

Shami¹

2017

Pharm Sci

View full text Add to dashboard Cite

“…It is native in regions of Southeastern Asia to Australia and currently has a pantropical distribution. 8 In Malaysia, M. citrifolia is commonly known as noni or mengkudu with other common names such as Indian mulberry, hai ba ji (China), and nuna (India). 9 M. citrifolia has been traditionally used to treat various ailments where the fruits, leaves, root, stem, and bark can be applied externally as a poultice or consumed orally as a decoction or in the form of fermented fruits.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and Safety of Morinda citrifolia L. (Noni) as a Potential Anticancer Agent

et al. 2022

View full text Add to dashboard Cite

Cancer is a major cause of morbidity and mortality worldwide and therefore there has been interest in discovering the phytoconstituents of medicinal plants exhibiting anticancer activities. Morinda citrifolia L., commonly known as Noni, has shown anticancer properties in in vitro, in vivo, and in clinical studies. A systematic review was conducted to collate scientific evidence on the anticancer properties of M. citrifolia using pre-determined keywords on 5 electronic databases: MEDLINE, CENTRAL, LILACS, Web of Science, and EBSCOHost. A total of 51 clinical and preclinical studies comprising 41 efficacy and 10 safety studies were included in this review. Our findings showed that M. citrifolia demonstrated various anticancer properties in different cancer models, via multiple mechanisms including antitumor, antiproliferative, pro-apoptotic, antiangiogenesis, antimigratory, anti-inflammatory, and immunomodulatory activities. M. citrifolia is deemed to be a potentially valuable medicinal plant in the treatment of cancer through its many intrinsic pathways. More well-designed and reported preclinical efficacy and safety studies are needed to allow for better translation into future clinical studies which could further substantiate the role of M. citriflolia in cancer treatment.

show abstract